Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ · Healthcare
Recursion Pharmaceuticals, Inc. Income Statement 2019–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenue | 74.7M | 58.8M | 44.6M | 39.8M | 10.2M | 4.0M | 2.3M |
| Gross Profit | 3.7M | 13.6M | 2.0M | -8.4M | 10.2M | 4.0M | — |
| Profitability | |||||||
| Operating Income | -648.1M | -479.0M | -350.1M | -245.7M | -182.8M | -84.6M | -62.4M |
| EBITDA | -564.4M | -442.5M | -325.7M | -234.0M | -174.4M | -80.7M | -60.0M |
| Net Income | -644.8M | -463.7M | -328.1M | -239.5M | -186.5M | -87.0M | -61.9M |
| Per Share Data | |||||||
| EPS (diluted) | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 447M | 274M | 208M | 176M | 125M | 22M | 22M |
Recursion Pharmaceuticals, Inc. Income Statement — FAQ
Recursion Pharmaceuticals, Inc. (RXRX) income statement over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RXRX's income statement history?
The chart and table above show Recursion Pharmaceuticals, Inc.'s income statement by year and by quarter, including the growth rate.